Iria Gomez-Tourino
University of Santiago de Compostela, GALICIA, Spain
- This delegate is presenting an abstract at this event.
I am Principal Investigator of the Immunity and Small Molecules lab at the Center for Research in Molecular Medicine and Chronic Diseases (CIMUS) of the University of Santiago de Compostela (Spain) since 2022, and Associate Professor of Immunology of the same university. My research career has always focused on the molecular mechanisms that drive autoimmunity, with a focus in Type 1 Diabetes. We made significant contributions to the autoimmunity field (e.g Nat Commun 2024, Diabetologia 2020, Nat Commun 2017), specifically in autoantigen discovery, autoimmune TCR profiling and autoantigen-specific T cell phenotyping.
My lab is focused in understanding the molecular mechanisms of autoimmunity, and how small molecules could be involved in both fostering and/or disrupting the functioning of the immune system, employing high-throughput techniques. For this, I received the Career Development Award from Breakthrough T1D (formerly JDRF, USA, 2023-2028, 1M$), to identify the self-antigens recognized by MAIT cells in T1D. This award is aimed to foster the careers of exceptionally promising researchers with disrupting ideas in the Type 1 Diabetes field. Additionally, and taking advantage of the excellent drug screening capabilities of our research centre, we also work in drug discovery in autoimmunity, as we identified a portfolio of novel and repurposed small molecules with previously unknown immunomodulatory properties.
I have been awarded several fellowships and awards, including two prestigious Marie Sklodowska-Curie Individual fellowships (King’s College London, UK, 2013-2015, and USC, Spain, 2018-2020), the Award to Young Researchers by the Royal Academy of Sciences of Galicia (2025), and the Career Development Award by Breakthrough T1D (2023). I am also the inventor of three patents, European Union Expert Evaluator, Nobel Laureate Lindau alumni, and elected member of the Board of Directors of the Spanish Society of Immunology (2022-2026). I am also very active in outreach activities.
I look forward to meeting other MR1/MAIT/TCR/autoimmunity enthusiasts and creating new networks, so feel free to reach out!
Presentations this author is a contributor to:
Identification of self-metabolites as MR1 ligands and autoantigens in Type 1 diabetes (#115)
5:00 PM
Lucía Mosquera-Ferreiro
Poster Session 1
High throughput discovery approaches identify human self-metabolites of several chemical classes as antigens for MAIT cells (#104)
5:00 PM
Iria Gomez-Tourino
Poster Session 1
Characterization of bile acids as novel MR1 ligands (#21)
4:49 PM
Alejandro Briones-Contreras
Lightning Talks 1
CD1-MR1 2025